Feline lymphoma

Specific disease presentations ALISON HAYES
In Practice (2006) 28, 578-585 specific immune stimulation. Two studies have alluded to this: in the first, lymphadenopathy was reported to regress over time in a group of younger cats diagnosed with lymphoma and presenting with generalised lymphadenopathy (Mooney and others 1987b) Four-year-old female domestic longhaired cat, which presented with signs of upper respiratory stridor and was FeLV-negative. Third eyelid protrusion and reduced retropulsion were noted, which were more marked on the right side. Nasal biopsy confirmed lymphoma and, after complete staging, chemotherapy was commenced with radiation therapy on relapse. Generalised lymphadenopathy is rarely a feature of lymphoma in cats Submandibular lymphadenopathy in a domestic shorthaired cat of unknown age. Multicentric lymphomas such as this rarely manifest as generalised peripheral lymphadenopathy, which is common in dogs. In this cat, there was marked, localised, unilateral enlargement of the submandibular node (arrow). Picture, Lorraine Fleming second, peripheral lymph node enlargement in 14 cats led to lymphoma in only one cat, with 13 cats undergoing spontaneous lymph node regression (Moore and others 1986 ). In the latter study, six out of nine cats tested had feline leukaemia virus (FeLV) antigen detected in the blood and had similar histology findings to kittens developing lymphadenopathy following experimental FeLV infection. In addition to histology, immunohistochemistry and FeLV antigen detection may be helpful in determining a definitive diagnosis. If there is any ambiguity, clinical monitoring and re-biopsy is advocated before making treatment decisions.
MEDIASTINAL LYMPHOMA
Mediastinal disease is a common presentation of lymphoma. Cats are often dyspnoeic, although sometimes this is not recognised by owners. Radiographic changes include an anterior thoracic mass effect with or without a pleural effusion. The thymus, mediastinal, presternal and other intrathoracic lymph nodes may all be affected. Lymphadenopathy may be appreciated in the thoracic inlet and lower cervical area. Displacement of the apex beat and dulled lung sounds will be heard on clinical examination. Regurgitation and dysphagia may also be reported by owners. Cytology of pleural fluid is usually supportive of the diagnosis, although histology is advisable wherever possible, especially in older cats that are FeLV-negative, in which the disease must be differentiated from thymoma, which may be treated surgically.
Ultrasound examination of the thorax facilitates guided fine needle aspiration or core biopsy of abnormal tissue. The presence of pleural fluid can aid ultrasonography, but due care is needed and thoracocentesis may be required for initial stabilisation before further investigation can take place. In cats, the right second to third or third to fourth intercostal space is a commonly used site for this. Care should be taken to avoid the intercostal vessels along the caudal aspect of the rib, while directing the needle along the thoracic wall to avoid lung trauma. A butterfly catheter or short over-the-needle catheter can be used, with or without extension tubing, and attached to a three-way tap and syringe for short-term drainage. The first fluid that is withdrawn should be placed into EDTA and plain tubes for cellular and biochemical analysis.
The mainstay of treatment for mediastinal lymphoma is cytotoxic chemotherapy, although low-dose radiation therapy to consolidate treatment can lead to durable remissions (Elmsie and others 1991) . Young, FeLV-negative, Siamese cats may be overrepresented, but can respond well to chemotherapy -often achieving complete and durable remissions, allowing treatment to be stopped.
ALIMENTARY LYMPHOMA
Alimentary (or gastrointestinal) lymphoma is frequently seen in cats. The small and large intestines, oral cavity, oesophagus, stomach, mesenteric nodes, pancreas and liver can all be involved. Presenting signs include weight loss, anorexia, lethargy and diarrhoea. Vomiting is not a consistent feature of the disease in cats. Intestinal involvement is generally regarded as a diffuse bowel disease, but may initially manifest as a solitary, focal mass detectable on abdominal palpation. Alternatively, abdominal palpation can reveal diffuse, cord-like bowel thickening. Abdominal ultrasonography is essential for diagnosis, staging and monitoring, and facilitates guided core and needle biopsy. Bowel thickening, loss of motility and layering, hypoechogenicity and lymphadenopathy are characteristic changes seen on ultrasound examination (Penninck and others 1994) .
When the disease presents as diffuse gastrointestinal changes, diagnosis may be achieved by ultrasound-guided needle or endoscopic grab biopsies prior to commencing chemotherapy. For more solitary masses, fine needle aspiration or needle-core techniques can be used. A surgical approach is required if definitive diagnosis is not achieved with non-invasive techniques such as Tru-cut style biopsies or when there is an immediate need to relieve bowel obstruction or intussusception. Superficial grab biopsies obtained endoscopically should be interpreted with caution, as these may underdiagnose lymphoma involving the Treatment can be surgical, medical or a combination of the two. Limitations apply to each form of treatment. Chemotherapy can be used as a first-line treatment if a definitive diagnosis has already been achieved by noninvasive means. However, large, focal mass lesions treated with chemotherapy can result in a full thickness defect once malignant lymphoid tissue is lost and close monitoring is required during the initial induction phase. Surgical resection of large areas of bowel does not appear to prolong survival compared with cats treated medically. Chemotherapy is advocated after recovery from surgical diagnostic and therapeutic procedures.
Cats with low-grade gastrointestinal lymphoma have been shown to respond well to a combination of prednisolone (10 mg per cat per day) and chlorambucil (15 mg/m 2 daily for four days, repeated every three weeks), achieving a median survival time of 22·8 months for the 67 per cent of animals that achieved complete remission (Fondacaro and others 1999) . In another study, which did not differentiate the grade of disease, 71 per cent of cats with gastrointestinal lymphoma achieved complete remission with a median survival time of 259 days and an overall median survival time for all cats of 201 days following treatment with a doxorubicin-based, six-drug protocol (Rassnick and others 1999) . However, two other studies have reported outcomes suggesting that cats with gastrointestinal lymphoma may respond less favourably to combination protocols than cats with other forms of the disease. Zwahlen and others (1998) reported that, of 21 cats treated with a doxorubicin-based, six-drug protocol, 38 per cent achieved complete remission with a median survival time of 291 days, and an overall survival time of 280 days for all cats. In the second study, Mahony and others (1995) reported that, of 27 cats treated with cyclophosphamide, vincristine and prednisolone (COP), 33 per cent achieved complete remission, with a median survival time of 213 days for those animals in complete remission and an overall survival time of 50 days.
As with other forms of the disease, the best chemotherapy protocol for gastrointestinal lymphoma is probably yet to be determined. However, from the limited studies to date, it appears that COP alone is probably inadequate for the management of gastrointestinal lymphoma.
RENAL LYMPHOMA
Renal lymphoma is the most common renal tumour in cats and often presents with acute-onset renal insufficiency, anorexia, weight loss and polyuria/polydipsia. Bilaterally enlarged, and sometimes irregular, kidneys can be found on palpation of the abdomen and confirmed radiographically. An apparent unilateral presentation can be encountered, although the disease is considered to be bilateral in all cases. Unsuspected renal involvement can be discovered during ultrasound examination if loss of corticomedullary definition is seen. This can be due to cortical infiltration by neoplastic lymphocytes. The diagnosis must be confirmed with fine needle aspiration or Tru-cut style biopsy. There may be an association between renal and nasal lymphoma, and also between renal and central nervous system lymphoma, but this is still unproven.
Treatment for renal lymphoma is always drug-based and can result in a rapid resolution of azotaemia, leaving relatively undamaged, functional kidneys. Surgical removal of a kidney for diagnostic purposes should be unnecessary and is not warranted from a therapeutic Right lateral recumbent projection of the abdomen of a seven-year-old domestic shorthaired cat with renal lymphoma. There is marked enlargement of both kidneys (cranial and caudal pole of each kidney shown by arrows), which has displaced the abdominal contents caudoventrally. These are typical signs of this condition in cats. This cat also had disseminated signs of disease, suggested by the pleural effusion
Lymphoma or IBD?
If there is a relationship between inflammatory bowel disease and lymphoma, it is a contentious one. The pathological classification of feline lymphocytic enteric disease has not yet been fully elucidated. Researchers have found that epitheliotropic intestinal lymphoma, characterised by infiltration of the superficial layers with small lymphocytes, can only be reliably differentiated from inflammatory bowel disease by identifying clonality on immunohistochemistry (Carreras and others 2003) and future molecular studies may aid further understanding. Currently, it is still unclear whether inflammatory bowel disease is a reaction or a precursor to lymphoma. Although it is tempting to regard these two diseases as a continuum of each other, this may prove to be inaccurate. Cats that show a poor response to inflammatory bowel disease therapy should be reviewed, and a diagnosis of lymphoma reinvestigated.
group.bmj.com on October 16, 2017 -Published by http://inpractice.bmj.com/ Downloaded from perspective. Survival times can be prolonged for cats with renal lymphoma; in one study involving 11 cats with disease confined only to the kidneys and treated with a multidrug protocol, the median survival time was 396 days (Mooney and others 1987a) . The degree of azotaemia should not be regarded as a prognostic indicator in cats with renal lymphoma. It is important to realise that reported median survival times may be unrepresentative of renal lymphoma per se, due to the possible link with central nervous system lymphoma and the more guarded prognosis that this carries.
Supportive care is required in cases of renal lymphoma, especially in the early stages of diagnosis and treatment. Cytotoxic drug dose reductions may be necessary in sick patients. Drug doses may be increased after the initial azotaemia has resolved. Special care should be taken with those drugs that require any degree of renal excretion (eg, cyclophosphamide). If used, doxorubicin should be administered with pre-and post-treatment fluid therapy; extreme care should be taken with cats with renal lymphoma, as this drug is nephrotoxic in this species.
CENTRAL NERVOUS SYSTEM LYMPHOMA
Lymphoma can affect the brain or spinal cord either as a main presenting sign or as a sign of progressive disease in cats undergoing treatment. Most cats with central nervous system involvement will also have lymphoma in sites other than the central nervous system. In the past, spinal lymphoma may have occurred more commonly, principally in FeLV-positive cats, but lymphoma in the brain was reported less frequently and in older, FeLV-negative cats. Clinical signs of brain involvement include irritability, seizures, circling, blindness, cranial nerve deficits and nystagmus. With spinal lymphoma, the onset of signs can be acute or insidious, and focal hyperaesthesia prior to clinical dysfunction has been reported. Paresis and ataxia with a rapidly deteriorating clinical course are common.
Definitive diagnosis can be difficult to achieve and may account for the relative under-reporting of brain involvement. Computed tomography or magnetic resonance imaging may detect a focal mass lesion, or a more infiltrative or widespread pattern of change. An accurate diagnosis may come from sampling other distant sites that are thought to be involved. Cerebrospinal fluid analysis may demonstrate malignant cells, but negative findings do not rule out lymphoma. The expected higher incidence of spinal lymphoma compared with lymphomas in the brain was not seen in a recent review of cases at the Animal Health Trust. This may reflect the changing face of feline lymphoma due to its FeLV/feline immunodeficiency virus associations.
Drug-based protocols for brain lymphoma may achieve less than expected for other forms of lymphoma, as most conventional cytotoxic drugs have minimal access across the blood-brain barrier. Protocols containing cytosine arabinoside have been advocated in an attempt to access affected areas. However, more success is generally achieved with radiation therapy, usually in conjunction with chemotherapy. Survival times of up to seven months have been reported, but usually the prognosis is regarded as poor. Spinal lymphoma is mainly extradural and thus should respond more favourably to drug-based therapies, although parenchymal extension can occur. Surgical decompression of the spine or adjuvant, low-dose radiation therapy may be considered on an individual case basis. Survival is affected as much by disease response to chemotherapy as by the timing of decompression, which can cause permanent neurological damage. Bone marrow analysis may yield a definitive diagnosis without the need for spinal surgery.
OCULAR LYMPHOMA
Ocular lymphoma can be unilateral or bilateral, and can precede the onset of systemic disease in many (but not all) cats. Any part of the eye and retrobulbar space can be affected. The uvea is most commonly affected and can show either diffuse or nodular changes. When other, systemic sites are thought to be involved, they should be sampled to help yield a definitive diagnosis. If an exact aetiology cannot be established, symptomatic treatment for uveitis can be implemented with regular re-evaluation. If there is a gross tumour within the eye and other sites are not involved, enucleation can be performed. In 
As with other forms of feline lymphoma, when ocular lymphoma is diagnosed, the possibility of systemic disease should prompt the use of adjuvant chemotherapy, although the clinician should be aware that some longterm survivors have been reported following enucleation alone.
TRACHEAL LYMPHOMA
Tracheal lymphoma is an uncommon but well recognised form of feline lymphoma. Cats can present with dyspnoea, wheezing, cyanosis, coughing and lethargy (Brown and others 2003) . Lesions can be visualised on plain radiography and bronchoscopy will aid collection of material for cytology. Successful treatment with chemotherapy has been reported, although radiation therapy can be used as a primary treatment modality, or as an adjunct to chemotherapy. As systemic disease can be seen at presentation or relapse, it is safest to assume that this form of lymphoma is part of a systemic disease and implement localised treatment as an adjunct to systemic therapy.
NASAL LYMPHOMA
Nasal lymphoma is also well recognised in cats. Affected animals can present with upper respiratory stridor, sneezing, nasal discharge, epiphora, and facial pain or deformation. Deviation or poor retropulsion of the globe should alert the clinician to the possibility of orbital extensions. Although radiographic displacement of midline structures, an increase in soft tissue opacity, loss of turbinate detail and bone invasion are all more likely to be seen in cases of nasal neoplasia, these changes are not specific for cancer versus rhinitis or for lymphoma versus any other intranasal neoplasia. As with other forms of lymphoma, careful staging is required. See Part 1 for a discussion of biopsy techniques.
Pre-(above) and post-radiotherapy (below) transverse postcontrast T1-weighted magnetic resonance images of a nasal lymphoma in a 10-year-old domestic shorthaired cat at the level of the caudal nasal cavity. Prior to treatment, a large mass can be seen filling the left nasal cavity, but it does not cross the nasal septum or invade the orbit (white arrow). Fluid is trapped within the left frontal sinus (black arrow). The post-treatment scan shows significant resolution; the soft tissue mass is no longer apparent and the trapped fluid has been allowed to drain. Radiotherapy can be useful for localised disease, as a combined modality treatment or rescue therapy Treatment can involve either chemotherapy or radiation therapy, or a combination of the two modalities. In the author's experience, long-term survival is achievable with radiation therapy alone, and in the absence of systemic involvement this is the preferred method of treatment when available. This is supported by the observations of other authors (Elmsie and others 1991) . However, systemic disease, even if absent at presentation, can manifest later in the course of disease and ultimately chemotherapy may be required. Conversely, relapsing nasal lymphoma treated by chemo therapy in the first instance, either due to systemic involvement or owner/vet preference, can be successfully rescued with radiation therapy. When nasal disease extends to the retrobulbar space, radiation of the globe may lead to long-term complications necessitating enucleation. A combined modality approach using chemotherapy to downsize the tumour (neoadjuvant therapy) may allow successful radiation therapy without irradiation of the globe. Repeated sectional imaging to monitor the response to drug-based treatment is essential in such cases prior to commencing chemotherapy.
OTHER FORMS OF LYMPHOMA
Other forms of lymphoma can be diagnosed in cats, either alone or as part of a multicentric presentation. When lymphoma of the lung occurs, it tends to manifest as nodular lesions, which are uncommon in dogs. Larnygeal lymphomas can cause respiratory stridor or 
Hodgkin's-like lymphoma
A specific form of feline lymphoma, termed Hodgkin's-like lymphoma, seems to be emerging. As the term suggests, there are pathological and clinical similarities to this specific human form of lymphoma. In people, Hodgkin's lymphoma tends to affect contiguous lymph nodes in the neck and thorax, and the disease can be slow to progress. Treatment is often based on surgery and radiation, rather than systemic drug therapy, which is more commonly associated with non-Hodgkin's lymphoma. The neoplastic cells (Reed-Sternberg) are in the minority and are found among non-neoplastic lymphocytes.
The feline form of the disease appears to affect older cats, which present with unilateral and often focal cervical or mandibular lymphadenopathy. A mixed population of lymphocytes is recognised with neoplastic cells seeming to be in the minority (Walton and Hendrick 2001) . A similar and possibly synonymous condition has been described by Day and others (1999) as a T cell rich B cell lymphoma. Further work is required to categorise this disease more specifically and document the clinical outcome. In the author's experience, neoadjuvant chemotherapy prior to localised lymph node excision for cervical lymphadenopathy has proved rewarding.
dyspnoea. Cutaneous lymphomas can be solitary or diffuse, and composed of T or B cells. Solitary cutaneous lymphomas can be cured surgically. In the case of multiple cutaneous lesions, or if surgical treatment is not indicated, treatment with conventional cytotoxic drugs can be attempted. Plesiotherapy and external beam radiation therapy may be useful as an adjunct to systemic treatment or as single modality therapy in areas that are deemed to be non-surgical.
SUMMARY
Lymphoma can present in many different guises, and the clinician should be alert to the possibility of this condition in any cat regardless of age, breed or viral status. Treatment can be rewarding with rapid responses often leading to a reversal of life-threatening situations within hours or days of commencing appropriate therapy in the practice setting. Histological diagnosis and full staging are required to tailor treatment choices to the individual cat. All samples for diagnostic purposes should be obtained before commencing therapy, including glucocorticoid treatment. On page 522, the dose for vincristine in the bottom table describing the MOPP protocol for rescue therapy should have read 0·025 mg/kg and not as stated.
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